SCHEMBL5066552

SCHEMBL5066552

CN1C(=S)NC(=O)C1(c1cccc(Br)c1)c1cccc(OS(=O)(=O)N2CCOCC2)c1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 5/20 0.33
MEN1 O00255 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALDH1A1 P00352 3/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
DCUN1D1 Q96GG9 1/20 0.32
MAPT P10636 2/20 0.31
CNR1 P21554 1/20 0.31
GALK1 P51570 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5067182 0.86 BACE1 (0.40) KMT2AATML3MBTL1LMNAMEN1
SCHEMBL4735172 0.84 DRD2 (0.32) RAB9AMAPTGAA
SCHEMBL5066480 0.83 HTR1A (0.32) KDM4E
SCHEMBL4514746 0.83 CNR1 (0.35) KMT2AATML3MBTL1LMNAMEN1
SCHEMBL5067168 0.82 RXFP1 (0.32) KMT2AMEN1RAB9A
SCHEMBL5063560 0.81 ALDH1A1 (0.33) KMT2AL3MBTL1LMNAMEN1SMN1; SMN2
SCHEMBL5066445 0.81
SCHEMBL5066204 0.80 LMNA (0.32) LMNAALDH1A1CNR1KDM4E
SCHEMBL5066550 0.78 RXFP1 (0.34) LMNARAB9AALDH1A1HTTKDM4E
SCHEMBL5066407 0.77 MMP2 (0.34) ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979324-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA Astra Zeneca AB (SE) 2008-10-15 EP claimed
WO-2007058602-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, NEURODEGENERATION AND DEMENTIA. ASTRAZENECA AB (SE) 2007-05-24 WO claimed
EP-1979324-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA Astra Zeneca AB (SE) 2008-10-15 EP disclosed
WO-2007058602-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, NEURODEGENERATION AND DEMENTIA. ASTRAZENECA AB (SE) 2007-05-24 WO disclosed